Trial intelligence / Profile preview

GSK1247446A vs Fluarix in Elderly (60+)

NCT00385840Phase 2Completed

Sponsor
GSK
Start
Oct 2006
Primary completion
Feb 2007
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of GSK1247446A in influenza, sponsored by GSK. Primary endpoint: Number of Subjects With Any and Grade 3 Solicited Local Symptoms at 7 days. Started Oct 2006; status: completed.

02

Drugs

GSK1247446A
03

Conditions

influenza

Beyond the preview

Go deeper on NCT00385840.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00385840.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call